摘要
Objective: To compare the long-term efficacy and safety of microwave ablation (MWA) as first-line therapy for hepatocellular carcinoma (HCC) adjacent versus nonadjacent to the gallbladder. @@@ Materials and Methods: From 2006 to 2018, 657 patients with <= 5 cm HCC who underwent percutaneous ultrasound-guided MWA as first-line therapy from 5 hospitals were enrolled in this retrospective study. Patients were grouped into the adjacent group (n = 49) and the nonadjacent group (n = 608) according to whether the tumor was adjacent to the gallbladder. Propensity score matching (PSM) was used to balance baseline variables between the two groups. @@@ Results: Forty-eight patient pairs were matched after PSM. For the PSM cohort, during a median follow-up time of 60 months, there were no differences in PFS (hazard ratio [HR], 1.011; 95% confidence interval [CI], 0.647-1.578; p = 0.963) or OS (HR 0.925; 95% CI 0.522-1.639; p = 0.789) between the adjacent and nonadjacent groups. Univariate and multivariate analyses revealed that the tumor adjacent to the gallbladder was not an independent risk factor for PFS or OS (all p > 0.05). Subgroup analysis showed comparable PFS and OS between the two groups in the <3 cm subgroup and the 3-5 cm subgroups (all p > 0.05). In addition to more use of assistive technology (p < 0.05), the adjacent group shared comparable local tumor progression, complications, technical success rate, and hospital stay (all p > 0.05) to the nonadjacent group. @@@ Conclusion: There were comparable long-term efficacy and complications between patients with HCC adjacent and nonadjacent to the gallbladder treated with MWA.
学科与关键词
- Long-term efficacy of microwave ablation in the treatment of subcapsular hepatocellular carcinomas of ≤3 cm in diameter: a multicenter, propensity score-matched studyYao, Jundong; Liu, Binbin; Wang, Xiaohui; Yu, Jie; Cheng, Zhigang; Han, Zhiyu; Liu, Fangyi; Zheng, Rongqin; Cheng, Wen; Qiang Wei; Yu, Songyuan; Li, Kai; Chen, Peng; Luo, Yanchun; Yu, Xiaoling*; Liang, Ping*International Journal of Hyperthermia, 2022, 39(1): 209-216.被引 2
- Period-Dependent Survival Benefit of Percutaneous Microwave Ablation for Hepatocellular Carcinoma: A 12-Year Real-World, Multicentric ExperienceYu, Jie; Cheng, Zhi-Gang; Han, Zhi-Yu; Liu, Fang-Yi; Zheng, Rong-Qin; Cheng, Wen; Wei, Qiang; Yu, Song-Yuan; Li, Qin-ying; He, Guang-zhi; Luo, Yan-chun; Yu, Xiao-Ling; Liang, Ping*Liver Cancer, 2022, 11(4): 341-353.被引 9
- Learning curve of microwave ablation for liver cancersDou, Jianping; Yu, Jie; Cheng, Wen; Wei, Qiang; Luo, Yanchun; Han, Zhiyu; Cheng, Zhigang; Liu, Fangyi; Yu, Xiaoling; Liang, Ping*EUROPEAN JOURNAL OF RADIOLOGY, 2023, 158: 110613.被引 1
